Volta Labs has successfully raised $25 million over two funding rounds, with backing from top venture capital firms and Y Combinator. The company is focused on building the most advanced DNA sequencing sample preparation machine, aiming to revolutionize biological automation.
Keep reading to explore the intricacies of Volta Labs' fundraising journey and the investors backing this innovative platform.
What Is Volta Labs?
Volta Labs, founded in 2018, is located in Kendall Square, Cambridge. The company was spun out of MIT and focuses on building advanced DNA sequencing sample preparation machines.
Co-founded by Udayan Umapathi and Will Langford, Volta Labs aims to solve the "sample prep bottleneck" in DNA sequencing. Their mission is to build biological automation from the ground up.
With a team of 11-50 employees, Volta Labs is in the growth stage, expanding its market presence and continuing to innovate in the field of genomics and synthetic biology.
How Much Funding Has Volta Labs Raised?
- Series A Round
- Amount Raised: $20 million
- Date: March 2022
- Lead Investors: Maverick Ventures
- Motivation Behind the Round: To outline a manufacturing plan and build out commercialization capacity. The capital will be used to develop a product strategy, build a commercialization team, and prepare for the commercial launch of their DNA sample prep instrument in 2023.
Volta Labs has raised a total of $20 million in funding. The current valuation is $100 million (~estimated).
Key Investors
- Y Combinator
- Details: Y Combinator is a startup accelerator that funds early-stage companies. It has a reputation for nurturing some of the most successful startups in Silicon Valley.
- Investment Focus Areas: Technology, biotech, hardware
- Notable Investments: Dropbox, Airbnb, Stripe
- Maverick Ventures
- Details: Maverick Ventures is a venture capital firm that invests in innovative startups. They led both the Series A and a previous seed round for Volta Labs.
- Investment Focus Areas: Healthcare, technology, consumer
- Notable Investments: Not specified
- Khosla Ventures
- Details: Khosla Ventures is known for investing in transformative technologies. They participated in the Series A round for Volta Labs.
- Investment Focus Areas: Healthcare, sustainability, technology
- Notable Investments: Square, DoorDash, Impossible Foods
- Casdin Capital
- Details: Casdin Capital specializes in life sciences and healthcare investments. They were part of the Series A round for Volta Labs.
- Investment Focus Areas: Life sciences, healthcare
- Notable Investments: Not specified
- E14 Funds
- Details: E14 Funds focuses on startups emerging from MIT’s media lab. They participated in the Series A round for Volta Labs.
- Investment Focus Areas: Technology, innovation, MIT startups
- Notable Investments: Not specified
What's Next for Volta Labs?
Volta Labs stands at the cusp of a significant opportunity in the rapidly evolving genomics industry. With the cost of genome sequencing plummeting, the need for efficient DNA sample preparation has never been more critical. Their innovative digital fluidics technology, which automates this process, positions them to address a major bottleneck in the field. Collaborations with companies in cancer care, neurological disorders, and synthetic biology further underscore the vast potential market.
As Volta Labs moves towards commercialization, future fundraising rounds will likely focus on scaling manufacturing and expanding their market reach. The recent $20 million Series A funding is a testament to investor confidence, and additional capital will be crucial for their growth. However, challenges remain, including proving the efficacy of their technology and competing with established players. Successfully navigating these hurdles will be key to their continued success.
Use Clay to Get Funding Data
Sales professionals, take your strategy to the next level by leveraging Clay’s platform to access comprehensive fundraising data on companies like Volta Labs and gather other critical business insights.
Sign up for free on Clay and start making data-driven decisions today.
